Dr. Peter GK Mathen, M.D.

Claim this profile
Studies Protoplasmic Astrocytoma
Studies Brain Tumor
1 reported clinical trial
1 drug studied

Clinical Trials Peter GK Mathen, M.D. is currently running

Image of trial facility.

Radiation Therapy

for Recurrent Brain Tumors

Background: Glioblastoma (GBM) is a cancer of the brain. Current survival rates for people with GBM are poor; survival ranges from 5.2 months to 39 months. Most tumors come back within months or years after treatment, and when they do, they are worse: Overall survival drops to less than 10 months. No standard treatment exists for people whose GBM has returned after radiation therapy. Objective: To find a safe schedule for using radiation to treat GBM tumors that returned after initial radiation treatment. Eligibility: People aged 18 years and older with grade 4 GBM that returned after initial radiation treatment. Design: Participants will be screened. They will have a physical exam with blood tests. A sample of tumor tissue may be collected. Participants will undergo re-irradiation planning: They will wear a plastic mask over their head during imaging scans. These scans will pinpoint the exact location of the tumor. This spot will be the target of the radiation treatments. Participants will undergo radiation treatment 4 times per week. Some people will have this treatment for 3 weeks, some for 2 weeks, and some for 1 week. Blood tests and other exams will be repeated at each visit. Participants will complete questionnaires about their physical and mental health. They will answer these questions before starting radiation treatment; once a week during treatment; and at intervals for up to 3 years after treatment ends. Participants will have follow-up visits 1 month after treatment and then every 2 months for 6 months. Follow-up clinic visits will continue up to 3 years. Follow-ups by phone or email will continue an additional 2 years.

Recruiting

1 award

Phase 1

More about Peter GK Mathen, M.D.

Clinical Trial Related

1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial

Treatments Peter GK Mathen, M.D. has experience with

  • Hypofractionation Trial Of Re-irradiation

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Peter GK Mathen, M.D. specialize in?

Is Peter GK Mathen, M.D. currently recruiting for clinical trials?

Are there any treatments that Peter GK Mathen, M.D. has studied deeply?

What is the best way to schedule an appointment with Peter GK Mathen, M.D.?

Is there any support for travel costs?